Aptose Biosciences Inc. Gains 26.86%
Thu, Nov 03, 2022 at 07:27 PM
Aptose Biosciences Inc. (APTO:NASDAQ) soared at $0.72, representing a gain of 26.9%. On Thu, Nov 03, 2022, APTO:NASDAQ touched a New 2-Week High of $0.72. The stock appeared on our News Catalysts scanner on Thu, Nov 03, 2022 at 11:03 AM in the 'BIOTECH' category. From Thu, Oct 20, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
About Aptose Biosciences Inc. (APTO:NASDAQ)
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology.
Top 10 Gainers:
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 242.8%
- Renovare Environmental Inc. (RENO:NASDAQ), 77.78%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Acutus Medical Inc. (AFIB:NASDAQ), 39.71%
- NerdWallet Inc. (NRDS:NASDAQ), 37.4%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 36.31%
- Aptose Biosciences Inc. (APTO:NASDAQ), 26.86%
- Provention Bio, Inc. (PRVB:NASDAQ), 26.09%
- Cardlytics, Inc. (CDLX:NASDAQ), 24.61%
- Greenhill & Co., Inc. (GHL:NYSE), 24.59%